Visual outcomes and satisfaction after IOL exchange with a novel full visual range IOL.
CLOSE
MENU

Visual outcomes and satisfaction after IOL exchange with a novel full visual range IOL.


Content provided by Bausch + Lomb Medical Affairs.

Visual outcomes and satisfaction after IOL exchange with a novel full visual range IOL.


Content provided by Bausch + Lomb Medical Affairs.

Summary

PURPOSE: To evaluate visual outcomes and patient satisfaction in patients who underwent intraocular lens (IOL) exchange surgery with a novel full visual range (FVR) IOL.

METHODS: This retrospective case series included patients dissatisfied with previously implanted IOLs (Clearview 3, Tecnis Odyssey, Alcon PanOptix or a monofocal IOL) who underwent IOL exchange with the enVista Envy FVR IOL. Outcome measures included uncorrected distance and near visual acuity. Subjective patient experience was also assessed following the exchange surgery.

RESULTS: Sixteen eyes of twelve patients underwent IOL exchange with the FVR IOL. Post-exchange, mean logMAR UDVA was 0.09±0.16, with 81.3% of eyes achieving 20/25 or better. Mean logMAR UNVA was -0.08+0.04, with 100% achieving 20/25 or better. Mean MRSE was -0.20±0.32 D. Patients exchanged from ClearView 3 to Envy reported resolution of glare, starbursts, and hazy vision. Patients exchanged from Odyssey noted fewer halos, better contrast, and improved peripheral vision. One eye that exchanged from PanOptix due to constant halos also reported improvement in subjective vision. All patients reported improved satisfaction.

CONCLUSION: Exchange to the enVista Envy FVR IOL provided good distance and near visual outcomes. Symptoms such as glare, starbursts, hazy vision, halos and peripheral vision blur reported with previously implanted IOLs resolved after exchange. Patients expressed high satisfaction with the Envy IOL compared to previously explanted IOLs.

For More Information:

Get Support

Contact Us

Contact a
Representative

Find My Local Rep link-out icon

Submit a
Medical Inquiry

Complete the Form